Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Teleflex experienced a dramatic 20% stock plunge on Thursday, hitting a new 52-week low of $136.60. Despite slightly exceeding analyst expectations with an adjusted earnings per share of $3.89, the ...

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the fourth quarter ended December 31, 2024. Fourth quarter financial ...

NEW YORK - Teleflex Incorporated (NYSE: TFX) saw its shares tumble over 21% on Tuesday after the medical technology company reported fourth quarter results that missed revenue exp ...

Teleflex shares tumbled to a 52-week low on Thursday after the medical-technology company posted disappointing financial guidance and unveiled plans for a nearly $800 million acquisition and a spinoff ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to ...